X0306 4 2017-08-09 0 0001488613 Foundation Medicine, Inc. FMI 0001320267 Daly David C/O FOUNDATION MEDICINE, INC. 150 SECOND STREET CAMBRIDGE MA 02141 0 1 0 0 Chief Commercial Officer Common Stock 2017-08-09 4 M 0 46872 22.24 A 163133 D Common Stock 2017-08-09 4 S 0 46872 39.50 D 116261 D Stock Option (right to buy) 22.24 2017-08-09 4 M 0 46872 0.00 D 2024-12-05 Common Stock 46872 28128 D The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.05 to $40.25, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote. This option was granted on December 5, 2014 and is exercisable (i) with respect to 25% of the shares subject to the options, on November 30, 2015, and (ii) with respect to 6.25% of the shares subject to the option, on each subsequent three month period beginning February 28, 2016 until fully vested. /s/ Robert W. Hesslein, as Attorney-in-Fact for David Daly 2017-08-10